Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Biognosys, Phenomenex

Premium

Biognosys has launched its new BloodSpotDive 100 multiple-reaction monitoring mass spec panel for dried blood spot analysis.

According to the company, the panel allows for routine quantification of 100 blood proteins directly from DBS samples. It is available as a fee-for-service product out of Biognosys' laboratory or for transfer to any lab equipped with a triple quadrupole mass spec.


Phenomenex has launched its 30 mm Kinetex core-shell 5-micron column for pharmaceutical lab-scale purifications.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.